Cyclacel Pharmaceuticals Inc.

NASDAQ: CYCC
Share price (3/28/25): $0.30
Market cap (3/28/25): $1.880 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 25 pages Contents Clause

from SC 13D 1 page Plan of reorganization, merger, acquisition or similar

from 8-K 3 pages Amendment No. 1 to the Stock Purchase Agreement

from 425 3 pages Amendment No. 1 to the Stock Purchase Agreement

from DEFA14A 3 pages Amendment No. 1 to the Stock Purchase Agreement

from 8-K 36 pages Definitions

from 425 36 pages Definitions

from DEFA14A 36 pages Definitions

from 425 75 pages Stock Purchase Agreement Between: Xcyte Therapies, Inc., a Delaware Corporation; and Cyclacel Group PLC, a Public Limited Company Organized Under the Laws of England and Wales. Dated as of December 15, 2005

from 8-K 75 pages Stock Purchase Agreement Between: Xcyte Therapies, Inc., a Delaware Corporation; and Cyclacel Group PLC, a Public Limited Company Organized Under the Laws of England and Wales. Dated as of December 15, 2005

from DEFA14A 75 pages Stock Purchase Agreement Between: Xcyte Therapies, Inc., a Delaware Corporation; and Cyclacel Group PLC, a Public Limited Company Organized Under the Laws of England and Wales. Dated as of December 15, 2005